Action Semnur Pharmaceuticals (PK) - SMNR

Semnur Pharmaceuticals Inc (PK) (SMNR) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

0,60

( -45,45% )

Prix Achat

0,69

Prix Vente

1,20

Volume échangé

73 854

0,515 Fourchette du Jour 1,25

0,25 Plage de 52 semaines 23,00

Cap du marché

138,125M

Clôture Veille

1,10

Ouverture

1,10

Dernière Transaction

0.69

Dernière heure de transaction

Volume financier

US$ 59 228

VWAP

0,801959

Volume moyen (3 m)

US$ 30 134

Actions en circulation

230 209 142

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-0,88

Bénéfice par action (BPA)

-0,77

Chiffre d'affairess (LTM)

Bénéfice net (LTM)

-164,33M

Semnur Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate is SP-102, a novel viscous gel formulation of corticosteroid to treat l... Semnur Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate is SP-102, a novel viscous gel formulation of corticosteroid to treat lumbosacral radicular pain, or sciatica, which is in the second Phase 3 study. The company was founded in 2013 and is headquartered in Palo Alto, California. Semnur Pharmaceuticals, Inc. operates as a subsidiary of Scilex Holding Company. Show more

Secteur

Finance

Industrie

Diversified Financial Services

Site Web

www.semnurpharma.com

Siège social

Palo Alto, United States

Fondé

2026

Semnur Pharmaceuticals Inc (PK) est coté dans le secteur Finance de la OTC Markets avec le ticker SMNR. Le dernier cours de clôture d'Semnur Pharmaceuticals (PK) était de US$1,10. Au cours de la dernière année, les actions de Semnur Pharmaceuticals (PK) ont été négociées dans une fourchette de prix de US$ 0,25 à US$ 23,00.

Semnur Pharmaceuticals (PK) compte actuellement 230 209 142 actions en circulation. La capitalisation boursière d'Semnur Pharmaceuticals (PK) est de US$138,13 million. Semnur Pharmaceuticals (PK) a un ratio cours/bénéfice (ratio PE) de -0.88.

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

PALO ALTO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”...

Form 8-K - Current report

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in Bit

PALO ALTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”...

Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin

PALO ALTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.12	25	0.48	1.31	0.32	99947	0.6726619	CS
4	-3.1	-83.7837837838	3.7	5	0.25	53418	0.64759605	CS
12	-4.4	-88	5	8	0.25	30000	0.66218999	CS
26	-22.4	-97.3913043478	23	23	0.25	21496	0.69299103	CS
52	-19.4	-97	20	23	0.25	13979	0.74751197	CS
156	-19.4	-97	20	23	0.25	13979	0.74751197	CS
260	-19.4	-97	20	23	0.25	13979	0.74751197	CS

SMNR - Frequently Asked Questions (FAQ)

What is the current Semnur Pharmaceuticals Inc (PK) share price?

The current share price of Semnur Pharmaceuticals Inc (PK) is US$ 0,60

How many Semnur Pharmaceuticals Inc (PK) shares are in issue?

Semnur Pharmaceuticals Inc (PK) has 230 209 142 shares in issue

What is the market cap of Semnur Pharmaceuticals Inc (PK)?

The market capitalisation of Semnur Pharmaceuticals Inc (PK) is USD 138,13M

What is the 1 year trading range for Semnur Pharmaceuticals Inc (PK) share price?

Semnur Pharmaceuticals Inc (PK) has traded in the range of US$ 0,25 to US$ 23,00 during the past year

What is the PE ratio of Semnur Pharmaceuticals Inc (PK)?

The price to earnings ratio of Semnur Pharmaceuticals Inc (PK) is -0,88

What is the registered address of Semnur Pharmaceuticals Inc (PK)?

The registered address for Semnur Pharmaceuticals Inc (PK) is 960 San Antonio Road, Palo Alto, California, 94303

What is the Semnur Pharmaceuticals Inc (PK) website address?

The website address for Semnur Pharmaceuticals Inc (PK) is www.semnurpharma.com

Which industry sector does Semnur Pharmaceuticals Inc (PK) operate in?

Semnur Pharmaceuticals Inc (PK) operates in the Diversified Financial Services sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Semnur Pharmaceuticals Inc (PK) (SMNR)

Semnur Pharmaceuticals Inc (PK) (SMNR) Action

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Semnur Pharmaceuticals Inc (PK)

SMNR Dernières nouvelles

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

Form 8-K - Current report

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in Bit

Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

Form 8-K - Current report

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in Bit

Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin

SMNR - Frequently Asked Questions (FAQ)

SMNR Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Semnur Pharmaceuticals Inc (PK) (SMNR)

Semnur Pharmaceuticals Inc (PK) (SMNR) Action

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Semnur Pharmaceuticals Inc (PK)

SMNR Dernières nouvelles

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

Form 8-K - Current report

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in Bit

Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

Form 8-K - Current report

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in Bit

Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin

SMNR - Frequently Asked Questions (FAQ)

SMNR Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités